Paralel Advisors LLC Purchases Shares of 4,883 HCA Healthcare, Inc. $HCA

Key Points

• Paralel Advisors acquired 4,883 HCA Healthcare shares worth approximately $1.9 million, while institutional investors collectively own 62.73% of the company.
• Analysts remain broadly positive, with 14 Buy, eight Hold and one Sell rating. However, several firms lowered their price targets; the consensus target is $462.64, compared with the stock’s recent price of $406.33.
• HCA beat quarterly expectations with $7.59 in adjusted EPS and $20.23 billion in revenue, up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, yielding about 0.8% annually.

Paralel Advisors LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,883 shares of the company's stock, valued at approximately $1,904,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Palisade Asset Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $26,000. MidFirst Bank purchased a new stake in HCA Healthcare during the second quarter valued at about $28,000. Clearstead Trust LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at about $29,000. Ares Financial Consulting LLC bought a new stake in HCA Healthcare in the 4th quarter worth approximately $31,000. Finally, Cedar Mountain Advisors LLC bought a new position in HCA Healthcare during the first quarter valued at approximately $33,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on HCA. The Goldman Sachs Group cut their price objective on shares of HCA Healthcare from $558.00 to $485.00 and set a "buy" rating for the company in a research note on Tuesday, July 28th. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. Truist Financial decreased their price objective on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Robert W. Baird reduced their price target on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a research report on Monday, July 27th. Finally, TD Cowen lowered their price objective on HCA Healthcare from $500.00 to $431.00 and set a "buy" rating for the company in a research report on Monday, June 22nd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $462.64.

HCA Healthcare Trading Down 0.2%

HCA Healthcare stock opened at $406.33 on Friday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The firm has a market cap of $87.97 billion, a P/E ratio of 13.60, a P/E/G ratio of 1.41 and a beta of 1.10. The firm has a 50-day moving average of $396.32 and a 200-day moving average of $444.25.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the prior year, the company posted $6.84 EPS. HCA Healthcare's quarterly revenue was up 8.7% compared to the same quarter last year. Research analysts forecast that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's payout ratio is presently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source